DelMar Pharmaceuticals Presents Promising VAL-083 Interim Data from GBM Clinical Trial at ASCO May 31, 2014
DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO May 14, 2014
Why is glioblastoma so deadly? DelMar discusses the need for new cancer research and treatments for Brain Tumor Awareness Month May 1, 2014
DelMar Pharmaceuticals VAL-083 Clinical Trial in GBM Demonstrates Continued and Promising Progress at AACR Apr 9, 2014
DelMar Pharmaceuticals to Present Two Abstracts at American Association of Cancer Research (AACR) Annual Meeting Apr 2, 2014
DelMar Pharmaceuticals Gives Quarterly Shareholder Update and Announces Investor Conference Call Mar 20, 2014
